Response to Comment on Rasmussen et al. A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers. Diabetes Care 2015;38:1723–1729

We appreciate the comments made by Muller et al. (1) to our recent article in Diabetes Care (2). Their findings corroborate those of ours, including the logistics for dissemination of technology, the lack of ownership among the number of stakeholders in a complex setup, the need for patient stratification to define particular subgroups that might or might not benefit from telemedical monitoring, and other aspects. The lack of difference in mortality in the research data from the Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management (AIRPEDIA) can, as mentioned in the …